This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

ASCP Corner

Why Aren’t MAOIs Used More Often?

Jan Fawcett

Published: January 15, 2009

Article Abstract

While I have spent most of my last 45 years in psychiatry
working in an academic setting and doing clinical research, I
have always had an active practice focused on major affective
disorders, especially treatment-resistant or treatment-refractory
cases. It is my impression that monoamine oxidase inhibitors
(MAOIs) are currently underutilized in the clinical practice of
psychiatry. Very few of the treatment-resistant patients that I
see have received a serious trial of MAOI therapy.

Volume: 70

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...